Table 4.
Correlation between serum CIP2A and clinicopathologic characteristics of patients with CRC (n = 63)
| Characteristics | Cases | CIP2A protein | P | |
|---|---|---|---|---|
| Low expression | High expression | |||
| Gender | 0.960 | |||
| Female | 37 | 23 | 14 | |
| Male | 26 | 16 | 10 | |
| Age | 0.967 | |||
| ≥ 65 | 25 | 15 | 10 | |
| < 65 | 38 | 23 | 15 | |
| Location | 0.163 | |||
| Colon | 17 | 7 | 10 | |
| Rectum | 46 | 28 | 18 | |
| T stage | 0.775 | |||
| T1-T2 | 35 | 20 | 15 | |
| T3-T4 | 28 | 17 | 11 | |
| N stage | 0.907 | |||
| N0 | 40 | 22 | 18 | |
| N1-N2 | 23 | 13 | 10 | |
| M stage | 0.407 | |||
| M0 | 37 | 21 | 16 | |
| M1 | 26 | 12 | 14 | |
| TNM stage | 0.509 | |||
| I-II | 37 | 23 | 14 | |
| III-IV | 26 | 14 | 12 | |
| Histological grade | 0.368 | |||
| Well | 26 | 17 | 9 | |
| Poorly-Moderately | 37 | 20 | 17 | |
| CEA | 0.002 | |||
| ≥ 5 | 10 | 2 | 8 | |
| < 5 | 53 | 38 | 15 | |
| CA19–9 | 0.014 | |||
| ≥ 37 | 14 | 4 | 10 | |
| < 37 | 49 | 32 | 17 | |